Literature DB >> 31351968

Berberine induces ZIP14 expression and modulates zinc redistribution to protect intestinal mucosal barrier during polymicrobial sepsis.

Yan He1, Xiaoming Yuan2, Hao Zuo2, Xiangwei Li2, Ying Sun2, Aiwen Feng3.   

Abstract

AIMS: The present study investigated if berberine might induce Zrt-Irt-like protein 14 (ZIP14) and affect zinc redistribution to protect intestinal barrier in sepsis. MAIN
METHODS: Rodent model of sepsis was induced by cecal ligation and puncture (CLP). Plasma endotoxin was assayed by LAL test and plasma zinc was measured by flame atomic spectrophotometer. Gut mucosal permeability was determined by plasma FITC-dextran. Zinc content and ZIP14 mRNA in gut mucosa were assayed by spectrophotometer and qRT-PCR, respectively. Tight junction integrity of Caco-2 was evaluated by transepithelial electrical resistance (TEER). Tight junction (TJ) protein expression was detected by Western blotting. KEY
FINDINGS: Berberine and zinc gluconate pretreatment to CLP rats improved survival rate, reduced plasma endotoxin level, alleviated hypozincemia, increased zinc accumulation and ZIP14 mRNA expression in the intestinal mucosa. Berberine and zinc gluconate pretreatment decreased CLP-elicited intestinal hyperpermeability to FITC-dextran. These effects of berberine in vivo were abolished by AG1024. In vitro, lipopolysaccharide (LPS) repressed zinc transfer into Caco-2 cells exposed to zinc gluconate. Berberine and IGF-I treatment increased ZIP14 protein expression and promoted zinc transfer into Caco-2 cells exposed to zinc gluconate plus LPS. Berberine treatment induced TJ protein (claudin-1 and occludin) and raised TEER in LPS-treated Caco-2 cells. These effects of berberine in vitro were partially inhibited by ZIP14 siRNA. SIGNIFICANCE: The present study reveals that berberine induces ZIP14 expression and affects zinc re- distribution to protect intestinal barrier in sepsis, which is partially linked with the activation of IGF-I signaling.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Berberine; IGF-I; Intestinal mucosal barrier; Sepsis; Tight junction; ZIP14; Zinc redistribution

Mesh:

Substances:

Year:  2019        PMID: 31351968     DOI: 10.1016/j.lfs.2019.116697

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Protective effects of vitamin D against injury in intestinal epithelium.

Authors:  Carol Lee; Ethan Lau; Sinobol Chusilp; Rachel Filler; Bo Li; Haitao Zhu; Masaya Yamoto; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2019-10-14       Impact factor: 1.827

2.  Enhanced IL-10 inhibits proliferation and promotes apoptosis of HUVECs through STAT3 signaling pathway in sepsis.

Authors:  Zuohua Xie; Bing Lin; Xinju Jia; Ting Su; Ying Wei; Jiping Tang; Chengzhi Yang; Chuanbao Cui; Jinxiang Liu
Journal:  Histol Histopathol       Date:  2021-09-16       Impact factor: 2.303

3.  Berberine attenuates sepsis-induced cardiac dysfunction by upregulating the Akt/eNOS pathway in mice.

Authors:  Hong Zhang; Xiaofei Wu; Yanyan Tao; Guoyu Lu
Journal:  Exp Ther Med       Date:  2022-04-05       Impact factor: 2.447

Review 4.  The Aging Bowel Dysfunction and Elderly Vulnerability towards COVID-19 Infection.

Authors:  Aaron Lerner; Mark F McCarty
Journal:  Life (Basel)       Date:  2021-01-28

Review 5.  Traditional Chinese Medicine: A promising strategy to regulate inflammation, intestinal disorders and impaired immune function due to sepsis.

Authors:  Xu-Hua Wang; Ding-Qiao Xu; Yan-Yan Chen; Shi-Jun Yue; Rui-Jia Fu; Lu Huang; Yu-Ping Tang
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

Review 6.  Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy.

Authors:  Katherine M DiGuilio; Elizabeth Rybakovsky; Reza Abdavies; Romy Chamoun; Colleen A Flounders; Ariel Shepley-McTaggart; Ronald N Harty; James M Mullin
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.